Washington biotech startups still able to capture capital
| March 20, 2008 |  View for printing |
Washington may not have the nation's biggest biotech market, but startups still attract millions in venture capital. Geography isn't as much of a hurdle as the general competition for money.
Last year, the state saw 11 rounds of funding for biopharmaceutical companies totaling $253.4 million, according to MoneyTree Report data compiled by Thomson Financial for PricewaterhouseCoopers and the National Venture Capital Association.
Puget Sound Business Journal (Seattle) - by Robert Celaschi
Full Story: http://seattle.bizjournals.com/seatt ... 400^1603687
***
Sen. Baucus Announces $28 Million Investment in Ligocyte Pharmaceuticals, Inc. of Bozeman, Montana http://matr.net/article-28279.html
No reader comments so far. Be the first to comment by clicking the button below.
Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.
